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Targeting AID
A dangerously mutagenic protein is targeted to a single genomic site by 
ssDNA, report Ronai et al. (page 181).
High frequency mutation at the immunoglobulin V region improves 
antibody affinity and specificity as part of the adaptive immune response. 
AID (activation-induced cytidine deaminase), which converts 
deoxycytidines to deoxyuridines, initiates this mutation process. These 
conversions then induce various error-prone repair mechanisms, increasing 
the mutation rate further.
AID must be targeted carefully, however, as it is a potent mutagen. 
Indeed mistargeting of AID-induced mutations is thought to cause B 
cell lymphomas.
AID’s only in vitro substrate is ssDNA. The team isolated chromatin 
from B cells undergoing somatic hypermutation (SHM) and found that 
chromatin- and transcription-dependent ssDNA was present at V regions.
Many genes in B cells are highly transcribed, but the team found that 
such loci had much less ssDNA than those undergoing SHM. The ssDNA 
may be short lived during normal transcription but persist at V regions, 
perhaps due to RNA pol II pausing. Whatever the reason, it seems that the 
specific abundance of ssDNA at the V region might be one of the 
chromatin signals for targeting AID. 
Activating autoimmunity
Why the body is sometimes attacked by its own 
immune system is largely a mystery. Work by 
Hirota et al. (page 41) suggests how an under-
lying genetic predisposition might combine with 
an environmental factor—specifically, an unrelated 
infection—to give rise to rheumatoid arthritis 
(RA) and possibly other autoimmune disorders.
A mouse model for RA, called SKG, has a 
single mutation in the ZAP-70 gene that causes an 
abundance of highly self-reactive T cells to enter 
the circulation. In a pathogen-free environment 
these mice are healthy, but when exposed to 
pathogens the mice develop autoimmune arthritis.
When these mice start to mount an immune 
response, such as that induced by a pathogen, 
their antigen-presenting cells (APCs) increase 
production of the IL-6 cytokine, the team shows. 
This IL-6 triggers the T cells to proliferate rapidly 
and differentiate into Th17 cells, which produce 
vast amounts of the proinflammatory cytokine 
IL-17. SKG mice that lacked either IL-17 or IL-6 
were protected from arthritis.
Some potentially arthritogenic Th17 cells 
already exist in the pathogen-free mice due to 
the constant interaction between APCs and T 
cells. Activation of the Th17 cells is minimal 
without pathogen, but an increase in IL-6 
during an immune response to a microbe, 
coupled with the constant exposure to self 
antigens, is just enough to tip these precariously 
balanced T cells into overdrive.
IL-17 levels have been shown to be high in a 
number of autoimmune disorders, including 
RA. Furthermore, mutation of a protein in the 
same pathway as ZAP-70 is a common genetic 
risk factor for RA. It is possible, therefore, that 
similar genetic and environmental factors also 
come together to produce RA in humans. 
T cells that remember a previously 
encountered virus are essential in 
establishing protective immunity. 
But some T cells have a longer life-
time, and thus effectively a longer 
immunological memory, than others. 
Work by Riou et al. (page 79) might 
explain why effector memory T cells 
(TEM) are short lived, whereas central 
memory T cells (TCM) are maintained 
in the body long-term.
The longer-lived TCM mainly reside in secondary lymphoid organs 
such as the lymph nodes, whereas the TEM are found in the peripheral 
tissues and sites of infection. The exact ontogeny of the two cell types 
is unknown, but it’s thought that TCM might give rise to the more 
transient TEM fighters. Regardless of origin, the biological basis for their 
different life spans was unknown.
Dendritic cells (DCs) were a good starting point, as they are known 
to produce the T cell survival factor IL-7. The team added dendritic 
cells to the two memory cell populations and found that the TCM 
proliferation response was more vigorous, perhaps because IL-7 (and 
IL-2) more efficiently activated the pro-survival factor STAT5 in TCM.
Even without DCs, TCM were less susceptible to apoptosis. These 
cells had less active pro-apoptotic transcription factor FOXO3a and 
lower transcription of its targets. FOXO3a activity is inhibited by 
phosphorylation, and adding IL-7 or IL-2 to the TCM increased 
FOXO3a phosphorylation at a particular residue, suggesting these 
cytokines might promote the long-term survival of TCM by both 
increasing proliferation and decreasing death. 
IL-2– and IL-7–induced 
phosphorylation of FOXO3a (top) 
may promote survival of TCM.
Pathogens encourage the production of self-reactive 
T cells, which cause autoimmune arthritis (purple, 
infiltrating cells).
Memory maintenance